Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × zimberelimab × 30 days × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 3 Stomach Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Adenocarcinoma Of Esophagus 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urothelial Bladder Carcinoma 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms 1 Metastatic Urothelial Cancer 1 Kidney Neoplasms 1 Esophageal Neoplasms 1 Erythrocytosis, Familial, 4 1 Carcinoma, Transitional Cell 1

Interventions

Rituximab 19 Cyclophosphamide 19 Prednisone 13 Lenalidomide 11 Doxorubicin 11 Oxaliplatin 9 Gemcitabine 9 fludarabine 8 Specimen Handling 8 Vincristine 7 Magnetic Resonance Spectroscopy 7 polatuzumab vedotin 6 Etoposide 6 glofitamab 5 CT-P10 5 venetoclax 4 obinutuzumab 4 ibrutinib 4 fludarabine phosphate 4 axicabtagene ciloleucel 4 Biopsy 4 deltacortene 3 Prednisolone 3 Leukapheresis 3 Ifosfamide 3 prednylidene 2 pembrolizumab 2 acalabrutinib 2 Whole-Body Irradiation 2 Spinal Puncture 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡